Product Name :
DuP 734
Description:
DuP 734 is a sigma receptor antagonist. DuP 734 is a selective and potent sigma and 5-HT2 receptor ligand with weak affinity for D2 receptors. DuP 734 may have antipsychotic activity without the liability of motor side effects typical of neuroleptics.
CAS:
135135-87-4
Molecular Weight:
356.27
Formula:
C17H23BrFNO
Chemical Name:
2-[1-(cyclopropylmethyl)piperidin-4-yl]-1-(4-fluorophenyl)ethan-1-one hydrobromide
Smiles :
Br.O=C(CC1CCN(CC1)CC1CC1)C1C=CC(F)=CC=1
InChiKey:
QLZIAKMYJFJBKA-UHFFFAOYSA-N
InChi :
InChI=1S/C17H22FNO.BrH/c18-16-5-3-15(4-6-16)17(20)11-13-7-9-19(10-8-13)12-14-1-2-14;/h3-6,13-14H,1-2,7-12H2;1H
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
DuP 734 is a sigma receptor antagonist. DuP 734 is a selective and potent sigma and 5-HT2 receptor ligand with weak affinity for D2 receptors. DuP 734 may have antipsychotic activity without the liability of motor side effects typical of neuroleptics.|Product information|CAS Number: 135135-87-4|Molecular Weight: 356.27|Formula: C17H23BrFNO|Chemical Name: 2-[1-(cyclopropylmethyl)piperidin-4-yl]-1-(4-fluorophenyl)ethan-1-one hydrobromide|Smiles: Br.O=C(CC1CCN(CC1)CC1CC1)C1C=CC(F)=CC=1|InChiKey: QLZIAKMYJFJBKA-UHFFFAOYSA-N|InChi: InChI=1S/C17H22FNO.BrH/c18-16-5-3-15(4-6-16)17(20)11-13-7-9-19(10-8-13)12-14-1-2-14;/h3-6,13-14H,1-2,7-12H2;1H|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 250 mg/mL (701.71 mM; Need ultrasonic).|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vivo:|DuP 734 potently blocks mescaline-induced scratching (ED50=0.{{Plerixafor} medchemexpress|{Plerixafor} Anti-infection|{Plerixafor} Purity & Documentation|{Plerixafor} Purity|{Plerixafor} custom synthesis|{Plerixafor} Autophagy} 35 mg/kg, p.{{(±)-Nornicotine-d4} site|{(±)-Nornicotine-d4} Membrane Transporter/Ion Channel|{(±)-Nornicotine-d4} Technical Information|{(±)-Nornicotine-d4} Purity|{(±)-Nornicotine-d4} manufacturer|{(±)-Nornicotine-d4} Epigenetics} o.PMID:31899014 ) and aggressive activity (ED50=1.9 mg/kg, p.o.) and is relatively much weaker as an apomorphine antagonist (ED50=12 mg/kg, p.o.). Administration of DuP 734 potently antagonizes the binding of [3H]DuP 734 and [3H](+)-SKF 10,047 to brain sigma receptors in vivo with ID50 values of 0.02 and 0.07 mg/kg (0.07 and 0.25μmol/kg), respectively. Following intravenous dosing, the disposition of DuP 734 in mice, rats, beagle dogs and cynomolgus monkeys is characterized by high total body systemic plasma clearance (46 to 87 mL/min/kg) and large steady-state volume of distribution (3.6 to 6.8 L/kg). The terminal elimination half-life ranged from 50 to 83 min. The gastrointestinal absorption from an aqueous solution is very rapid in mice and rats with peak DuP 734 plasma concentrations attain within 5 and 20 min following administration, respectively. The peak plasma concentrations in dogs and monkeys are attained within 45 and 130 min, respectively. The absolute bioavailability in mice ranges from 29 to 46% at doses of 3.1 to 30.1 mg/kg. The bioavailability increases from 4 to 10% and from 14 to 72% when doses are increased from 12.5 to 50 mg/kg and 1 to 3 mg/kg of DuP 734 in rats and dogs, respectively. The bioavailability in monkeys is 30.5% at 9.3 mg/kg DuP 734 dose. The dose dependent pharmacokinetics of DuP 734 is observed within narrow dose ranges in all animal species investigated.|Products are for research use only. Not for human use.|
